Silexion Therapeutics Corp

CUSIP G1281K130ORD SHS NEWQ4 2025

Silexion Therapeutics Corp — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

14.7%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

5 filings · latest Feb 13, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 13, 2026	Mitchell P. Kopin	13G/A	9.4%	325.0K	SEC
2	Sep 23, 2025	Moringa Sponsor, LP	13D/A	14.7%	—	SEC
3	Sep 17, 2025	Mitchell P. Kopin	13G	10.0%	244.8K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Citadel Advisors LLC	12.2K	$23.4K
2	Montag A & Associates Inc	3.0K	$5.8K
3	Ubs Group AG	1.7K	$3.2K
4	Sbi Securities Co., Ltd.	1.1K	$2.0K
5	Pflug Koory, LLC	333	$639
6	Jones Financial Companies Lllp	26	$50